Stephen James Bryant

HIGHLIGHTS

• Recipient of multiple travel awards for Sales Performance and Business Growth – 2 Apex and 3 Managing Directors Awards (all expenses paid trips for 2 to domestic and international locations including Las Vegas USA, Cancun Mexico, Istanbul Turkey, Singapore, Uluru and Margaret River WA)
• Sales award winner for performance is 2018 - Development opportunity to attend World Business Forum meeting in Sydney.
• Sales award winner for performance in 2022 - Incentive payment.
• Recipient Lilly Hero Award – Peer-voted award for execution excellence
• Recipient Queensland Business Excellence Award - Peer-voted award for business excellence

IMMUNE SPECIALITY (Dermatology and Rheumatology)

• First territory to establish a higher market share the direct competitor of same class in the IL-17 space. Achieved 18 months post launch and still the case after 6 years in market
• Territory still maintains highest market share in PsO nationally
• Pioneered a biologics management program utilising established nursing expertise to train clinical staff in the safe and efficient use of biologics
• Part of the team launching Lilly’s first monoclonal antibody for psoriasis into Dermatology
• Also launched subsequent indications for this product in Rheumatology
• Part of the team launching Lilly’s first small molecule (JAKi) for Atopic Dermatitis into Dermatology
• Successful investigation of new customer base and the applicability and value of the medication to individual customers
• Leading the team in the use of electronic P2P programs so as to include regional and remote customers

NEUROSCIENCE SPECIALTY

• First to establish a significant patient base for new long acting injectable drug – Zyprexa Relprevv
• Coordinate and facilitate training for different customer types, including nurses, pharmacists, doctors and community mental health staff
• Pioneered a referral pathway for Zyprexa Relprevv clients from Queensland Mental Health services to primary care
• This referral practice is now seen as Gold Standard for these clients
• Advised on the implementation of the first dedicated depot antipsychotic clinic nationally
• Consistently lead the team in unit sales per month and market share with growth rate above national average
• Lead the team in optimising business planning skills, building customer relationships and strategic mapping of accounts
• Achieve more patient initiations than any other team member nationally
• Responsible for 22% national depot market but accounting for almost 40% of the unit sales
• Promoted to Territory Manager

• Manage the negotiation of individual business contracts
• Responsible for the achievement of sales targets, and management of territory profit margins
• Responsible for the expansion of customer base within a designated territory
• Manage product stock levels
• Plan and manage new business programs against set targets
• Report competitor intelligence and organise promotions
• Filled sales management role as required
• Achievements
• Achieved highest growth and market share for a new bio-similar of the antidepressant Cipramil. Significant financial incentive awarded
• Consistently achieved above sales targets and territory profit margin targets
• Expanded territory customer base by 20 per cent.

• One of three Top sales award recipients nationally for exemplary performance which included highest market share growth for a primary care diabetes medication - Actos, and attainment of a higher market share for Cialis exceeding the market leader, Viagra
• Recipient of two travel awards for high sales performance and leadership – one Apex and one Managing Directors Award
• Received a peer nominated award for exceptional performance and leadership qualities – Lilly Hero Award
• Recipient of Queensland Sales Excellence Award for outstanding sales results
• Promoted to Sales Consultant which included taking on responsibility for mentoring and coaching other team members
• Streamlined a coaching model for scientific up-skilling for the team involving clinical paper analysis and implementation in the sales call
• Achieved top level sales performance for all 3 brands, across three different disease states encompassing diabetes, osteoporosis and erectile dysfunction
• Managed additional territory on an interim basis due to staff vacancy, and maintained highest level of sales in both territories
• Held Business Advocacy role for various brands, which involves market testing of sales materials and models
• Achieved superior program implementation by attracting high numbers of influential attendees to drive sales growth.